China has now approved GLP-1 therapies from Eli Lilly (Mounjaro), Innovent Biologics (mazdutide), and Guangzhou Innogen (efsubaglutide alfa), in addition to Xianyida
Neurosci Res aprile
Tatsumi, R., Hattori, A., Ikeuchi, Y., Anderson, J
It is not guaranteed approval if you meet BMI criteria
Complete approach: Selank: 300mcg daily via intranasal spray Semax: 400mcg daily via intranasal spray Optional: Low-dose growth hormone peptides for neuroprotection Optional: NAD+ for cognitive energy and cellular health Implementation schedule: Morning: Semax 400mcg (focus and cognitive enhancement) Afternoon: Selank 300mcg (anxiety reduction and stress resilience) Optional: Growth hormone peptides in evening for recovery and neuroprotection Duration: Continuous use with periodic 4-week breaks every 3-6 months to prevent tolerance
*For patients, out-of-pocket costusually in the form of a co-insurance percentage of the list priceis not the only factor determining their preferred choice of Humira-reference biosimilar